CASP8 -652 6N del polymorphism and cancer risk: A meta-analysis of 30 case-control studies in 50 112 subjects

Mutagenesis

Volumn 27, Issue 5, 2012, Pages 559-566

  Zhangy, Fan ^a   Yang, Yuan ^a   Guo, Cheng ^b   Wang, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER RISK; CASPASE 8 652 6N GENE; COLORECTAL CANCER; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

CASE-CONTROL STUDIES; CASPASE 8; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; RISK;

EID: 84867291621     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges019     Document Type: Article

References (41)

1. Carson, D. A. and Ribeiro, J. M. (1993) Apoptosis and disease. Lancet, 341, 1251-1254.
2. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
3. Chen, M. and Wang, J. (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis, 7, 313-319.
4. Nuñez, G., Benedict, M. A., Hu, Y. and Inohara, N. (1998) Caspases: the proteases of the apoptotic pathway. Oncogene, 17, 3237-3245.
5. Grenet, J., Teitz, T., Wei, T., Valentine, V. and Kidd, V. J. (1999) Structure and chromosome localization of the human CASP8 gene. Gene, 226, 225-232.
6. Frank, B., Hemminki, K., Wappenschmidt, B. et al. (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis, 27, 606.
7. Palanca Suela, S. S., Esteban Cardeñosa, C. E., Barragán González, E. et al. (2010) CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res. Treat., 119, 87-93.
8. Yang, C., Hu, H. Z. and Fu, Z. X. (2011) PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8. Cell Biol. Int., 36, 289-296.
9. Engel, C., Versmold, B., Wappenschmidt, B. et al. (2010) Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol. Biomarkers Prev., 19, 2859-2868.
10. Lubahn, J., Berndt, S. I., Jin, C. H. et al. (2010) Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate, 70, 646-653.
11. Bethke, L., Sulivan, K., Webb, E. et al. (2009) CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett., 273, 312-315.
12. Bethke, L., Sulivan, K., Webb, E. et al. (2008) The common D302 variant of CASP8 is associated with risk of glioma. Cancer Epidemiol. Biomarkers Prev., 17, 987-989.
13. Sun, T., Gao, Y., Tan, W. et al. (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet., 39, 605-613.
14. Theodoropoulos, G. E., Gazouli, M., Vaiopoulou, A., Leandrou, M., Nikouli, S., Vassou, E., Kouraklis, G. and Nikiteas, N. (2011) Polymorphisms of Caspase 8 and Caspase 9 gene and colorectal cancer susceptibility and prognosis. Int. J. Colorectal Dis., 26, 1113-1118.
15. Yin, M., Yan, J. R., Wei, S. and Wei, Q. Y. (2010) CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis, 31, 850-857.
16. De Vecchi, G., Verderio, P., Pizzamiglio, S. et al. (2009) Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast Cancer Res. Treat., 113, 607-608.
17. Catucci, I., Verderio, P., Pizzamiglio, S. et al. (2011) The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Res. Treat., 125, 855-860.
18. Srivastava, K., Srivastava, A., Kumar, A. and Mittal, B. (2011) Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. PLoS One, 6, e16449.
19. De Martino, M., Klatte, T., Waldert, M., Remzi, M., Haitel, A. and Marberger, M. (2011) The six nucleotide insertion/deletion polymorphism rs3834129 in the caspase8 promoter is associated with risk and progression of renal cell carcinoma. Eur. Urol. Suppl., 10, 106.
20. Oskina, N. A., Ganov, D., Petrova, V. D., Lazarev, A. F., Lifshits, G., Filipenko, M. L. and Boyarskih, U. A. (2010) Genetic susceptibility to prostate cancer in residents of the west Siberian region. J. Clin. Oncol., 28, 15.
21. Srivastava, K., Srivastava, A. and Mittal, B. (2010) Cluster analysis of risk factor genetic polymorphisms in gallbladder cancer. HUGO J., 4 (Suppl), 97.
22. Haiman, C. A., Garcia, R. R., Kolonel, L. N., Henderson, B. E., Wu, A. H. and Le Marchand, L. (2008) A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat. Genet., 40, 259-260(author reply 260-1).
23. Chatterjee, K., Williamson, A. L., Hoffman, M. and Dandara, C. (2011) CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer. J. Med. Virol., 83, 630-636.
24. Frank, B., Rigas, S. H., Bermejo, J. L. et al. (2008) The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res. Treat., 111, 139-144.
25. Cybulski, C., Wokołorczyk, D., Gliniewicz, B. et al. (2008) A sixnucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res. Treat., 112, 367-368.
26. Pittman, A. M., Broderick, P., Sullivan, K., Fielding, S., Webb, E., Penegar, S., Tomlinson, I. and Houlston, R. S. (2008) CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br. J. Cancer, 98, 1434-1436.
27. Kesarwani, P., Mandal, R. K., Maheshwari, R. and Mittal, R. D. (2010) Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU Int., 107, 471-476.
28. George, G. P., Mandal, R. K., Kesarwani, P., Sankhwar, S. N., Mandhani, A. and Mittal, R. D. (2011) Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India. Urol. Oncol., 2011 March 14 [Epub ahead of print]. Doi:10.1016/j.urolonc. 2010.08.027.
29. Wang, M., Zhang, Z., Tian, Y., Shao, J. and Zhang, Z. (2009) A sixnucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer. Clin. Cancer Res., 15, 2567-2572.
30. Gangwar, R., Mandhani, A. and Mittal, R. D. (2009) Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann. Surg. Oncol., 16, 2028-2034.
31. Li, C., Zhao, H., Hu, Z. et al. (2008) Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mutat., 29, 1443-1451.
32. Ma, X., Zhang, J., Liu, S., Huang, Y., Chen, B. and Wang, D. (2011) Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. Gynecol. Oncol., 122, 554-559.
33. Umar, M., Upadhyay, R., Kumar, S., Ghoshal, U. C. and Mittal, B. (2011) CASP8 S652 6N del and CASP8 IVS12-19G.A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population. J. Surg. Oncol., 103, 716-723.
34. Yang, M., Sun, T., Wang, L. et al. (2008) Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin. Cancer Res., 14, 3230-3236.
35. Srivastava, K., Srivastava, A. and Mittal, B. (2010) Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. Mol. Carcinogen., 49, 684-692.
36. Liamarkopoulos, E., Gazouli, M., Aravantinos, G., Tzanakis, N., Theodoropoulos, G., Rizos, S. and Nikiteas, N. (2011) Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer, 14, 317-321.
37. Li, C., Lu, J., Liu, Z., Wang, L. E., Zhao, H., El-Naggar, A. K., Sturgis, E. M. and Wei, Q. (2010) The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev. Res., 3, 246-253.
38. Son, J. W., Kang, H. K., Chae, M. H. et al. (2006) Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet. Cytogenet., 169, 121-127.
39. Xiao, M. S., Zhang, D. F., Zeng, Y., Cheng, Y. F. and Yao, Y. G. (2011) Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients. Ann. Hematol., 90, 1137-1144.
40. Zhu, J., Qin, C., Wang, M. et al. (2010) Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol. Carcinogen., 49, 810-817.
41. Siegel, R. M. (2006) Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol., 6, 308-317